Novel Haplotype Indicator for End-Stage Renal Disease Progression among Saudi Patients

Table 2

Frequency of SHROOM3 haplotypes compared between patient stratified by CKD, ESRD, and control cohorts.

Groups	Haplotype	Frequency	Chi square	value
Control vs. patients	GG	0.69	0.507	0.4765
	AA	0.24	1.525	0.2168
	GA	0.04	0.035	0.8512
	AG	0.03	1.91	0.1669
Control vs. CKD	GG	0.69	0.563	0.4531
	AA	0.24	2.098	0.1475
	GA	0.04	0.002	0.963
	AG	0.03	2.383	0.1227
Control vs. ESRD	GG	0.69	0.824	0.3639
	AA	0.23	0.155	0.6939
	GA	0.05	1.998	0.1575
	AG	0.04	0.052	0.8203
CKD vs. ESRD	GG	0.66	0.014	0.9052
	AA	0.27	0.807	0.369
	GA	0.05	1.49	0.2222
	AG	0.02	1.514	0.2186